Not finding it? Sign in to also search OpenAlex live.
-
Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT
Nico Gagelmann, Dirk‐Jan Eikema, Linda Köster, Tanja Netelenbos, Andrew Bruce McDonald, Anne‐Marie Stoppa, +19 more
0citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
1citations -
Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT
Xavier Poiré, Diderik-jan Eikeman, Linda Köster, Johan A. Maertens, Jan J. Cornelissen, Nathalie Fegueux, +18 more
0citations -
Transplant Outcomes in Patients with Ph+ Chronic Myeloid Leukemia: Haploidentical Donors Compared to Matched Sibling Donors and Matched/Mismatched Unrelated Donors: A Retrospective Analysis from the EBMT Chronic Malignancies Working Party (EBMT-CMWP)
Francesco Onida, Ge Junran, Linda Köster, Rose‐Marie Hamladji, Jenny Byrne, Victoria T. Potter, +18 more
0citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
D. van der Heijde, P.J. Mease, C. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
4citations -
P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results2020 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Walker, Bernard G Combe, Alan J. Kivitiz, Yoshiya Tanaka, Désirée M F M van der Heijde, Franziska G. Matzkies, +10 more
1citations -
POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
X. Baraliakos, A. Deodhar, Désirée M F M van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, +6 more
1citations -
P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results2020 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Neil D McKay, Désirée M F M van der Heijde, René Westhovens, William F. C. Rigby, D. W. T. CHING, Beatrix Bartók, +10 more
0citations -
POS0900 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES OVER 2 YEARS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Florian Proft, Désirée M F M van der Heijde, Sergio Schwartzman, Joerg Ermann, A. Marten, Ute Massow, +6 more
0citations
16 results